The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?
Martin J. van den Bent*, Pim J. French, Daniel Brat, Joerg C. Tonn, Mehdi Touat, Benjamin M. Ellingson, Robert J. Young, Johan Pallud, Andreas von Deimling, Felix Sahm, Dominique Figarella Branger, Raymond Y. Huang, Michael Weller, Ingo K. Mellinghoff, Tim F. Cloughsey, Jason T. Huse, Kenneth Aldape, Guido Reifenberger, Gilbert Youssef, Philipp KarschniaHoutan Noushmehr, Katherine B. Peters, Francois Ducray, Matthias Preusser, Patrick Y. Wen
Research output: Contribution to journal › Review article › Academic › peer-review
8Citations
(Scopus)
5Downloads
(Pure)
Fingerprint
Dive into the research topics of 'The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?'. Together they form a unique fingerprint.